Dendritic cells (DCs) play a crucial role in antigen presentation (3, 4) . Immature DCs found mostly in nonlymphoid organs, such as Langerhans cells of the skin, continuously filter the surrounding liquids and carry the antigens or infectious microorganisms to the draining lymph nodes. There they differentiate into professional antigen-presenting cells, called interdigitating DCs, which prime naive T cells to become efficient effector cells (3, 29-31, 36, 51, 52, 55) .
B cells are inefficient at inducing immune responses with naive T cells (9, 14, 15, 18, 20, 44, 48) . On the other hand, however, they are good presenting cells for antigen-experienced T cells when they express an antigen-specific Ig (11, 37, 54) . Most likely, the nature and the density of costimulation molecules required for the long duration of priming observed in the context of DCs in vivo and in vitro is responsible for this difference (29, 40) . DCs have also been shown to directly activate B cells when the T cell-DC interaction is replaced by anti-CD40 treatment (13) .
T-cell/B-cell collaboration induced by mouse mammary tumor virus (MMTV) infection is indistinguishable from classical antigen responses in lymph nodes (40) and is therefore a valuable model to study T-cell/B-cell collaboration in vivo. MMTV preferentially infects B cells, which then present the superantigen (Sag) in the context of major histocompatibility complex (MHC) class II on their cell surface (2, 5, 25, 26) . Sag-presenting B cells receive help from the large number of T cells expressing Sag-specific T-cell receptor V␤ chains. The infected B cells divide and differentiate in both extrafollicular and follicular B-cell compartments, similarly to classical B-cell responses in terms of localization, surface marker phenotypes, antibody secretion, and kinetics (40, 41) . After the initial expansion, the Sag-reactive T cells are slowly deleted from the repertoire by peripheral clonal deletion (27, 43, 46, 64) .
Although the importance of B cells during MMTV infection has been clearly demonstrated, we were interested to know whether other types of antigen-presenting cells might also be required to mount an efficient Sag-induced immune response. Indeed, since such a response can be considered a primary immune response, and since B cells are usually not efficient in the activation of naive T cells, we addressed the question of whether professional antigen-presenting cells such as DCs could play a cooperative role in the activation of Sag-reactive T cells (32) .
We show here, using MMTV(SIM), a viral isolate which requires MHC class II I-E expression to induce a strong Sag response in vivo (42) , that transgenic mice expressing I-E exclusively on DCs (I-E␣DC tg) reveal a strong Sag response. This Sag response is dependent on the presence of B cells as indicated by the absence of stimulation in I-E␣DC tg mice lacking B cells (I-E␣DC tg MT Ϫ/Ϫ ), even if these B cells lack I-E expression. Furthermore, the involvement of either residual transgene expression by B cells or transfer of I-E from DCs to B cells could be excluded by the use of mixed bone marrow chimeras. Our results clearly demonstrate that following professional T-cell priming by DCs, T-cell/B-cell interactions become productive in the immune response induced by the MMTV Sag.
RESULTS

T-cell expansion induced by the MMTV(SIM) Sag in mice expressing I-E exclusively on DCs. The MMTV(SIM) Sag interacts with V␤4-expressing CD4
ϩ T cells and requires MHC class II I-E expression to induce a strong Sag response in vivo (42) . This last property has been demonstrated previously in C57BL/6 mice, which do not express MHC class II I-E molecules, compared with transgenic C57BL/6 mice expressing I-E␣ under the control of the MHC class II promoter (I-E␣ tg) and thus expressing I-E on all MHC class II positive cells. To further understand the respective roles of different types of antigen-presenting cells, we used transgenic C57BL/6 mice expressing I-E␣ specifically on DCs but not on B cells or other MHC class II positive cells (I-E␣DC tg). Such a phenotype has been generated through the use of the CD11c promoter to specifically drive I-E␣ expression in the DC compartment. I-E␣DC tg mice have normal levels of I-E on DCs, with undetectable I-E expression on B cells as shown by flow cytometry (6, 7) .
Injection of MMTV(SIM) into the footpads of C57BL/6 mice did not induce an increase in the percentage of the Sagreactive T cells in the draining popliteal lymph node (Fig. 1,  left) , whereas in I-E␣ tg mice a strong Sag response was detected ( Fig. 1, middle) . This was true with virus doses contained in 2 to 0.02 l of milk. Interestingly, transgenic mice expressing I-E exclusively on DCs (I-E␣DC tg) showed a strong, albeit slightly lower, Sag response ( Fig. 1, right) , indicating that expression of I-E in the DC compartment is critical to prime the T-cell response to the MMTV Sag. Indeed, recent immunohistochemical observations have suggested that DCs could be involved in priming of Sag-reactive T cells (41) .
B cells contribute to the Sag response in I-E␣DC tg mice. To determine the contribution of B cells in the immune response induced by the MMTV(SIM) Sag in I-E␣DC tg mice, the transgenic mice were crossed and backcrossed to C57BL/6 MT Ϫ/Ϫ mice, which lack B cells due to disruption of the gene segment encoding the IgM transmembrane region (33) . In this way, we generated I-E␣DC tg MT Ϫ/Ϫ mice, expressing I-E on DCs but lacking B cells. Injection of MMTV(SIM) into the footpads of these mice did not induce an increase in the percentage of Sag-reactive V ␤ 4 ϩ CD4 ϩ T cells in the draining lymph node (Fig. 2) . As a positive control, I-E␣DC tg MT Ϫ/Ϫ mice were infected with a recombinant vaccinia virus expressing the MMTV(GR) Sag (34) . Such an infection induced a large increase in the percentage of Sag-reactive T cells (data not shown), indicating that the T cells are able to respond to Sag in these B cell-deficient mice. Taken together, these results indicated that DCs are efficient presenters in the Sag response induced by MMTV(SIM) but that a measurable response is dependent on the presence of B cells.
The MMTV(SIM) Sag is presented to T cells in C57BL/6 mice. Although C57BL/6 mice failed to show a detectable expansion of Sag-reactive T cells in the draining lymph node, it was important to define whether the MMTV(SIM) Sag can also be presented to a lower extent to T cells in the absence of MHC class II I-E molecules. To address this question, we studied the deletion of V ␤ 4 ϩ CD4 ϩ T cells after MMTV(SIM) infection. Indeed, systemic deletion of Sag-reactive T cells is a much more sensitive readout for a Sag response than the early localized expansion that was detectable in the draining lymph node (23) . Two microliters of MMTV(SIM)-containing milk was injected into the footpads of C57BL/6, C57BL/6 I-E␣ tg, or C57BL/6 I-E␣DC tg mice. The percentage of V ␤ 4 ϩ cells among CD4
ϩ peripheral blood lymphocytes was determined at various time points after infection (Fig. 3) . The most rapid and complete deletion of V ␤ 4 ϩ CD4 ϩ T cells was observed in I-E␣ tg mice (Fig. 3, middle) . Interestingly, a slow and small but significant deletion occurred in C57BL/6 mice in the absence of I-E (Fig. 3, left) . C57BL/6 I-E␣DC tg mice had an intermediate magnitude and kinetics of deletion (Fig. 3, right) . These results indicate a weak but detectable Sag presentation in the absence of I-E. In addition, the slower deletion kinetics in I-E␣DC tg mice compared to those in I-E␣ tg mice can probably be explained by the weak priming capacity of Sag-presenting I-E-negative B cells. Overall, the presentation of the MMTV(SIM) Sag by I-A is estimated to be at least 100 times weaker than its presentation by I-E [see Fig. 1 , compare the absence of response in C57BL/6 mice with 2 l of MMTV(SIM)-containing milk to the detectable response in I-E␣DC tg mice with 0.02 l of MMTV(SIM)-containing milk].
MMTV Sag-dependent B-cell differentiation in mice expressing I-E exclusively on DCs. The previous experiments indicated that expression of I-E on DCs in the presence of B cells was required to prime a strong T-cell response to the MMTV(SIM) Sag. Since DCs seemed to be the main antigenpresenting cells in the induction of this primary immune response, we were interested in determining whether B cells would still receive T-cell help and undergo T-dependent B-cell differentiation in I-E␣DC tg mice (39) . MMTV(SIM) was injected into the footpads of C57BL/6, C57BL/6 I-E␣ tg, or C57BL/6 I-E␣DC tg mice. Cells from the draining popliteal lymph node were recovered at day 6 after infection and were studied by using an ELISPOT assay for Ig secretion and flow cytometric analysis for the expression of B-cell differentiation markers. B-cell differentiation was comparable in I-E␣ tg and I-E␣DC tg mice (Fig. 4) . Total numbers of IgM-and IgGsecreting B cells were similar in both types of transgenic mice (Fig. 4a) . No IgM-and IgG-secreting B cells could be detected in C57BL/6 mice in the same experiment (data not shown). The IgG isotype pattern was somewhat different in I-E␣DC tg mice, with a higher number of IgG 2a and a lower number of IgG 1 -producing B cells, perhaps reflecting a different pattern of cytokine secretion in the two transgenic mice. In addition, extrafollicular B-cell differentiation was assessed by flow cytometry through the detection of syndecan-1, a plasma cell differentiation marker (Fig. 4b) . Both types of transgenic mice had a similar percentage of syndecan-1 expression among plasma blasts (FSC high /B220 ϩ /MHC class II low cells) at day 6 after infection with MMTV(SIM), whereas the expression of this marker in C57BL/6 mice remained at the background level. In summary, these results clearly indicated that B cells could receive adequate T-cell help and could differentiate normally in I-E␣DC tg mice, even in the absence of I-E expression in the B-cell compartment.
Generation of bone marrow chimeric mice. The results described so far could be explained (i) by a requirement of I-E expression on DCs for T-cell priming, (ii) by expression of I-E by B cells due to a slight leakiness of the CD11c promoter used for the DC-specific I-E expression, or (iii) by transfer of I-E molecules from transgene-expressing DCs to B cells. To test these possibilities, experiments with bone marrow chimeras were performed. I-E␣DC tg mice were crossed and backcrossed with MT Ϫ/Ϫ mice to generate I-E␣DC tg MT Ϫ/Ϫ mice, expressing I-E on DCs but lacking B cells. Mixed bone marrow chimeras with I-E␣DC MT Ϫ/Ϫ and C57BL/6 bone marrow were generated. In these chimeras, all the B cells originated from the C57BL/6 bone marrow, expressing I-A but not harboring the I-E transgene. In the DC compartment, expression of I-E was shown to correlate with the mixing ratio of the two bone marrows (e.g., 50% of the DCs in the chimera expressed I-E if equal amounts of bone marrow cells were injected, data not shown).
At least 6 weeks after reconstitution, the bone marrow chimeras were infected with MMTV(SIM) by footpad injection, and cells of the draining popliteal lymph node were recovered at day 4 after infection. The percentage of CD4 ϩ T cells or CD4 ϩ T-cell blasts expressing V ␤ 4 was determined using flow cytometry (Fig. 5) . As expected, the negative control, C57BL/6 into C57BL/6 chimeras, had no increase in the percentage of V ␤ 4 ϩ cells among CD4 ϩ T-cell or T-cell blasts. As the positive control, I-E␣DC tg into C57BL/6 mice had a strong Sag response to the MMTV(SIM) Sag. Interestingly, mixed bone marrow chimeras with I-E␣DC MT Ϫ/Ϫ and C57BL/6 bone marrow also showed a strong response to the MMTV(SIM) Sag. This response was comparable in magnitude to that of the positive control. Minor differences in the degree of response could be correlated to variations in the percentage of reconstitution of the DC compartment with I-E-expressing DCs. Indeed, titration experiments with different ratios of I-E␣DC tg and C57BL/6 bone marrow showed that optimal results were obtained when at least 50% of the DC cells in the chimeras were of I-E␣DC tg origin (data not shown). Overall, these results indicated that residual transgene expression by B cells was not the explanation for the effects described in Fig. 1 and 3 (if residual expression had been the explanation, no Sag response would have been observed in the bone marrow chimeras).
Finally, mixed bone marrow chimeras with I-E␣DC MT Ϫ/Ϫ and C57BL/6 I-A Ϫ/Ϫ bone marrow were prepared and challenged with MMTV(SIM). These mice were similar to the other chimeras, except that the B cells expressed neither I-E nor I-A. No Sag response was observed in these mice (Fig.  5, bottom) , indicating that transfer of I-E from DCs to B cells could not be the explanation for the Sag response in I-E␣DC tg mice [if transfer of I-E had been the explanation, these chimeras would have responded to the MMTV(SIM) Sag]. Therefore, a major contribution of I-E-dependent Sag presentation by B cells in I-E␣DC tg mice could be excluded.
Priming of Sag-reactive T cells by DCs led to an increased recognition of Sag molecules presented on B cells by I-A.
MMTV initially infects only a few B cells, leading to Sagdependent amplification of the infected cells, with little bystander activation (25, 26, 40) . A strong infection at the peak of the response would indicate preferential amplification of the infected B cells and, hence, Sag presentation by I-A. In the case of a polyclonal activation that is not dependent on Sag presentation by I-A, weak infection levels would be maintained at the peak of the response, since there is no preferential amplification of the infected B cells. To address this question, we extracted the cellular DNA from total lymph node cells 4 days after MMTV(SIM) injection and performed a PCR analysis to detect proviral sequences. Figure 6 shows a strong PCR signal at the peak of the Sag response in I-E␣ tg mice as well as in I-E␣DC tg mice as opposed to a weak PCR signal for the I-E-negative C57BL/6 mice. The endogenous integrated proviral sequences were amplified to control for DNA quantities (Fig. 6, bottom) . These results confirm a preferential amplification of the infected B cells.
To exclude the possibility that the strong infection is due to preferential virus spread to activated B cells, we blocked viral spread with the reverse transcriptase inhibitor AZT. We have previously shown by administration of AZT that the Sag response does not result from the spread of infectious virus to bystander-activated B cells but is due mostly to the division of the few initially infected cells (24) . Chronic application of AZT 36 h after infection blocks viral spread to bystander B cells but does not reduce the overall B-cell amplification. Furthermore, we have shown that the preferential amplification of infected cells under these conditions is due to the preferential division of the infected B cells due to T-cell help (24) . If MMTVinfected B cells receive help preferentially, an increase of the PCR signal is expected between days 2 and 4. Therefore, we used fluorescence-activated cell sorted B cells from I-E␣ tg and I-E␣DC tg mice and determined their infection levels (Fig. 7) . A comparably strong PCR signal was observed in both types of mice in the presence or absence of AZT. The relative infection levels increased 7.5-fold between days 2 and 4 as determined by instant imager analysis (data not shown) in both I-E␣DC tg and I-E␣ tg mice. As a control for the efficiency of AZT treatment, we treated mice with AZT before MMTV infection. This treatment results in a complete absence of a Sag response, absence of a PCR signal, and absence of an increase of lymph node size at day 4 (data not shown [24] ). These results confirm that after priming by DCs in the context of I-E, Sag can be recognized under highly limiting conditions in the context of I-A.
DISCUSSION
The findings reported in this article demonstrate that MMTV uses at least two different types of antigen-presenting cells to trigger a potent immune response to the viral Sag. Indeed, both B cells and DCs were shown to play a crucial role in this immune response, since the Sag response was undetectable or dramatically reduced if one of the two partners was absent or unable to fulfil its function. For example, this was the case in C57BL/6 mice, where B cells were present but DCs did not express the appropriate MHC class II molecules to prime the Sag-reactive T cells. Similarly, in I-E␣DC MT Ϫ/Ϫ mice, where DCs were present and functional but B cells were absent, no Sag response was detectable. Expression of the Sagpresenting MHC class II I-E molecule exclusively on DCs was sufficient to induce a strong Sag response, provided B cells expressing the weakly Sag-presenting MHC class II I-A molecules were present. Therefore, a response to previously undetectable amounts of antigen on the B-cell surface became possible after DC priming. The involvement of DCs in the early immune response to the MMTV SAg clarifies several aspects of the interaction between MMTV and the immune system (1). MMTV initially infects fewer than 100 B cells (25, 26) . It was thought previously that expression of the viral Sag at the surface of the B cells was able to induce a strong T-cell response, thus providing potent T-cell help to the infected B cells which started to differentiate and to divide, increasing dramatically the amount of proviral DNA. During this process, infected B cells were preferentially stimulated, since they expressed the viral Sag and received cognate T-cell help. However, B cells are known to be inefficient as antigen-presenting cells for naive T cells, and it was difficult to imagine how the few infected B cells would be sufficient to trigger a potent primary immune response. In fact, priming of the naive Sag-reactive T cells appears to require the presentation of the viral Sag by DCs. As professional antigen-presenting cells, DCs are able to present the Sag much more efficiently than B cells. Sag-reactive T cells primed by DCs probably have a lower antigen recognition threshold and can recognize the Sag presented by B cells under suboptimal conditions. In addition, interaction with DCs might also be required to induce costimulatory molecules such as CD40L in Sag-reactive T cells in order to prepare them for interaction with B cells (16, 61) . Indeed, mice lacking CD40L expression have been reported to be unable to sustain an MMTV-induced Sag response (10) .
If the MMTV Sag is presented both by B cells and by DCs, the question arises how the DCs acquire the Sag and whether they are also infected with MMTV (62) . In theory, several possibilities can be envisaged as follows. The first possibility is attractive. B cells were known to be the first targets of MMTV infection, but so far infection of DCs has not been reported. Retroviruses in general, with the exception of lentiviruses, are thought to require dividing cells to complete the proviral integration process, and DCs are known to be nondividing cells. The second possibility does not represent the classical way by which retroviral proteins are expressed, but small amounts of viral protein have been described to be produced in this way by avian retroviruses, e.g., avian myeloblastosis virus or Rous sarcoma virus (19, 28, 59 ). As few molecules of MMTV Sag are required to generate a potent biological effect, this possibility remains a potential explanation. The third possibility, advocating the presence of the Sag in the viral particles, would be compatible with the presence of small amounts of many viral and cellular proteins within other retroviral particles, e.g., human immunodeficiency virus (HIV). As the MMTV Sag is produced as a type II transmembrane protein, one would expect that the viral Sag is present within the viral membrane and gains access to the cell membrane upon fusion of the virus with the DC, even without further steps in the viral life cycle. Alternatively, the Sag would have to be processed to a soluble form, which could be transferred to the surface of the DC. Finally, a fourth possibility is that the Sag could be transferred from neighboring infected cells. This would require the transfer of membrane fragments of the donor cell containing the Sag or processing to a soluble form. The existence of such a processing and transfer has already been suggested by other groups with cell culture systems (12, 45, 47) as well as with earlier experiments on endogenous MMTV Sags in bone marrow chimeras (57, 58) .
It is interesting to compare our observations with data from studies on HIV infection. Although CD4 ϩ T cells are known to be the main target of HIV and to produce the largest amount of viral particles, the potential of HIV to infect DCs in vitro and in vivo has been the focus of intensive research in recent years. Conflicting reports have been generated initially as to the infectability of cultured DCs, with efficient replication reported by some groups but not by others (8, 35, 49, 66) . More recently, productive HIV infection has been described in immature but not mature DCs (21) . Interaction of HIV with the DCs has been shown to occur via multiple chemokine receptors (22, 53) . It is now generally thought that DCs or DC precursors are an important target cell type during early HIV infection, being perhaps the first cell type to be infected within the exposed mucosa and the carrier of the virus to neighboring lymphoid tissue (17, 50, 56) . In addition, DCs might play an important role as immune partners of the CD4 ϩ T cells, by allowing intercellular transfer of HIV and favoring productive infection through activation of the CD4 ϩ T cells (8, 65, 66 ). These observations have many similarities with our observations on the putative role of DCs in MMTV infection.
Finally, the cooperative involvement of B cells and DCs during MMTV infection is interesting for immunology in general, since the immune response induced by the MMTV Sag recapitulates in many aspects the response to a conventional antigen (40, 41) . Our results indicate that after priming by DCs in the context of I-E, the MMTV(SIM) Sag can be recognized under limiting conditions on the surface of B cells in the context of I-A. During this process, the avidity of the Sagreactive T cells for the Sag-MHC complex has to increase strongly. The most likely physiological relevance of our observation is to allow B cells with a low affinity for antigen to receive T-cell help in a primary immune response.
